By Justina Lee
WuXi AppTec Co. posted an 72% increase in net profit for 2021, supported by higher revenue contributions from its existing and new clients.
The pharmaceutical company’s 2021 net profit was 5.10 billion yuan ($800.3 million) compared with CNY2.96 billion the year before, as revenue rose 39% to CNY22.90 billion, it said Wednesday night.
The board proposed a cash dividend of CNY5.1740 per 10 shares, tax inclusive, to shareholders.
WuXi AppTec said that it will continue to enhance its capacity and expand globally.
“In terms of M&A strategy, the Company focuses on the acquisition of companies that will enhance the service capabilities of our platform and expand our global footprint to better service our global customers,” it said.
Write to Justina Lee at justina.lee@wsj.com
(END) Dow Jones Newswires
March 23, 2022 20:07 ET (00:07 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.